Ophthalmology · Richmond, VA
NPI
1619085214
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
5875 Bremo Rd, Suite 606
Richmond, VA, 23226
Phone (804) 484-3200
Groups this clinician bills Medicare through
Medicare paid, 2024
$473K
6,688 services
Medicare patients, 2024
1,499
Average age 77
Drug cost, 2024
$630K
9,327 prescriptions
Company payments, 2025
$24.99
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Francis A Larosa was code 99214 (office e&m - established), 1,465 times for 957 patients. In total Francis A Larosa billed 6,688 services in 43 codes, and Medicare paid $473K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-03-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,465 | 957 | $85.78 | $126K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,170 | 771 | $13.00 | $15K |
| 92133 Computerized Ophthalmic Imaging | Office | 945 | 849 | $26.00 | $25K |
| 92083 Vision, Hearing, and Speech Services | Office | 760 | 726 | $46.07 | $35K |
| 99213 Office E&M - Established | Office | 632 | 489 | $64.49 | $41K |
| 92014 Ophthalmological E&M | Office | 468 | 453 | $81.24 | $38K |
| 66984 Cataract Surgery | Facility | 187 | 111 | $353.33 | $66K |
| 68841 Eye | Facility | 151 | 93 | $13.05 | $1,970 |
| 92250 Angiography | Office | 128 | 122 | $25.42 | $3,254 |
| 92136 Ultrasound - Nonspecific | Office | 127 | 105 | $32.79 | $4,164 |
| 92025 Test - Miscellaneous | Office | 97 | 95 | $25.54 | $2,477 |
| 99204 Office E&M - New | Office | 91 | 91 | $109.04 | $9,923 |
| 66821 Cataract Surgery | Facility | 83 | 67 | $252.54 | $21K |
| 92020 Ophthalmological E&M | Office | 61 | 60 | $19.05 | $1,162 |
| 66174 Fluid Flow and Drainage of Eye (Any Method) | Facility | 39 | 24 | $504.07 | $20K |
By year: 2022 $450K for 4,851 services; 2023 $456K for 5,288 services; 2024 $473K for 6,688 services.
Medicare prescription drug claims, 2024
In 2024, the drug Francis A Larosa prescribed most often to Medicare patients was Latanoprost, with 3,034 prescriptions and refills. In total Francis A Larosa wrote 9,327 Medicare prescriptions that cost $630K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 3,034 | 7,144 | 861 | $30K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 1,381 | 3,516 | 417 | $34K |
| Brimonidine Tartrate Generic | 1,066 | 2,430 | 305 | $34K |
| Timolol Maleate Generic | 863 | 2,123 | 266 | $8,920 |
| Dorzolamide Hcl Generic | 579 | 1,337 | 178 | $11K |
| Prednisolone Acetate Generic | 521 | 686 | 301 | $21K |
| Moxifloxacin Moxifloxacin Hcl | 310 | 311 | 187 | $7,056 |
| Rhopressa Netarsudil Mesylate | 203 | 352 | 54 | $113K |
| Lumigan Bimatoprost | 186 | 365 | 51 | $89K |
| Rocklatan Netarsudil Mesylat/Latanoprost | 112 | 203 | 35 | $69K |
| Alphagan P Brimonidine Tartrate | 83 | 140 | 18 | $30K |
| Ketorolac Tromethamine Generic | 78 | 106 | 41 | $1,541 |
| Brinzolamide Generic | 77 | 157 | 21 | $14K |
| Travoprost Generic | 68 | 151 | 20 | $14K |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 66 | 125 | 22 | $11K |
Brand drugs: 2,148 claims; generic drugs: 7,179 claims; opioid claims: 15.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Francis A Larosa $24.99 ($24.99 in general payments such as food, travel and fees) from 1 company. The largest payer was Alcon Vision LLC with $24.99.
| Company | Payments | Amount |
|---|---|---|
| Alcon Vision LLC ALC | 1 | $24.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.